U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT06873659) titled 'SON-DP in Participants with Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors' on March 07.
Brief Summary: A Phase I Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of SON-DP in Subjects with Advanced Solid Tumors
Study Start Date: Feb. 26
Study Type: INTERVENTIONAL
Condition:
Solid Tumor
Gastric Cancer
Liver Cancer
Intervention:
DRUG: SON-DP
Solution for IV administration
Recruitment Status: RECRUITING
Sponsor: Qurgen Inc.
Published by HT Digital Content Services with permission from Health Daily Dig...